Notice of first launch, interruption or termination of supply of a human drug
 DateHolderCodeDrugDate from ▲Subject
 24.7.2026Biosimilar Collaborations Ireland Limited (BTT)9177CHulio 40 mg injekčný roztok v naplnenom pere (sol inj 2x0,8 ml/40 mg (pero napl.plast.+2 tamp.))20.8.2026R
 24.7.2026Pfizer Europe MA EEIG (PFI-BE-3)09711SOLU-MEDROL 500 mg (plv iol 1x500 mg+1x7,8 ml solv. (1x liek.inj.+1x liek.inj.))17.8.2026R
 13.8.2026Fresenius Kabi s.r.o. (FRK-CZ-3)5281CSmofKabiven extra Nitrogen (emu inf 4x1518 ml (vak Biofin))17.8.2026R
 20.7.2026Gedeon Richter Plc. (GDN)3380CAmelgen (glo vag 15x400 mg (strip PVC/PE))16.8.2026O
 18.6.2026Viatris Limited (VIM)30797Bisomyl Combi 2,5 mg/6,25 mg (tbl flm 30x2,5 mg/6,25 mg (blis.OPA/Al/PVC/Al))15.8.2026R
 12.8.2026Sandoz GmbH (SAN-A)65482Zarzio 30 MU/0,5 ml injekčný alebo infúzny roztok v naplnenej injekčnej striekačke (sol ijf 1x0,5 ml/30 MU (striek.inj.skl.napln. s ochr.krytom ihly))15.8.2026R
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)28912Ospamox 750 mg filmom obalené tablety (tbl flm 14x750 mg (blis.PVC/PVDC/Al))15.8.2026Z
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)52089Mykofenolát mofetil Sandoz 500 mg filmom obalené tablety (tbl flm 50x500 mg (blis.PVC/PE/PVDC/Al))15.8.2026R
 23.3.2026Novartis Europharm Limited (NEH-IE)2593BNEVANAC 3 mg/ml očné suspenzné kvapky (int opu 1x3 ml/9 mg (fľ. LDPE-oválna))15.8.2026R
 12.8.2026Sandoz Pharmaceuticals d.d. (SAN-SLO-1)52466Fludarabin Sandoz 25 mg/ml koncentrát na injekčný/infúzny roztok (con ijf 1x2 ml/50 mg (liek.inj.skl.))15.8.2026R
 5.8.2026B.Braun Melsungen AG (BME)13902Chlorid sodný B. Braun 0,9 % infúzny roztok (sol inf 10x500 ml (fľ.PE))14.8.2026R
 10.8.2026Fresenius Kabi s.r.o. (FRK-CZ-3)10085Neodolpasse (sol inf 1x250 ml (fľ.skl.))13.8.2026O
 13.8.2026Viatris Healthcare Limited (VIM-1)03739EFUDIX (ung 1x20 g (tuba Al))13.8.2026O
 13.8.2026B.Braun Melsungen AG (BME)34271Glukóza B. Braun 40 % koncentrát na infúzny roztok (con inf 20x10 ml (amp.LDPE-Mini-Plasco connect))13.8.2026O
 13.8.2026Neuraxpharm Pharmaceuticals, S.L. (NUH)10916BUCCOLAM 7,5 mg orálny roztok (sol ora 4x1,5 ml/7,5 mg (striek.orálna napln.PP))13.8.2026R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To



 
Processed by the system MCR.Prerusenie (8.0)